Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1081-1090 of 9364

Page
per page
  1. Cidofovir
    A5790 Cidofovir
    Target: CMV
    Summary: Anti-CMV drug;inhibitor of viral DNA syntheis
      insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL
  2. Ibuprofen Lysine
    A5791 Ibuprofen Lysine
    Summary: COX inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥17.62 mg/mL
  3. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  4. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: Selective MEK5 inhibitor
      ≥22.05 mg/mL
  5. BIX 02188
    A5803 BIX 02188
    Target: MEK
    Summary: MEK5 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥10.3 mg/mL
  6. AM1241
    A5827 AM1241
     2 Citation
    Summary: Cannabinoid CB2 receptor agonist,potent and selective
      ≥50.3 mg/mL
  7. Dapagliflozin
    A5854 Dapagliflozin
    Summary: SGLT2 inhibitor,potent and selective
  8. R406 (free base)
    A5880 R406 (free base)
    Summary: Syk inhibitor
      ≥23.5 mg/mL
  9. PHT-427
    A5884 PHT-427
    Summary: Akt and PDPK1 inhibitor
      insoluble in H2O; ≥20.5 mg/mL
  10. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL

Items 1081-1090 of 9364

Page
per page